These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29764230)

  • 41. Psychosis, agitation, and antipsychotic treatment in dementia.
    Devanand DP
    Am J Psychiatry; 2013 Sep; 170(9):957-60. PubMed ID: 24030608
    [No Abstract]   [Full Text] [Related]  

  • 42. Current attitudes regarding treatment of agitation and psychosis in dementia.
    Serby MJ; Roane DM; Lantz MS; Cohen AJ; Turok A; Perlis TE
    Am J Geriatr Psychiatry; 2009 Feb; 17(2):174. PubMed ID: 19155750
    [No Abstract]   [Full Text] [Related]  

  • 43. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.
    Lesser JM; Hughes S
    Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimer's Disease (CATIE-AD): baseline characteristics.
    Ismail MS; Dagerman K; Tariot PN; Abbott S; Kavanagh S; Schneider LS
    Curr Alzheimer Res; 2007 Jul; 4(3):325-35. PubMed ID: 17627490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of drugs by Old Age Psychiatrists in the treatment of psychotic and behavioural symptoms in patients with dementia.
    Condren RM; Cooney C
    Aging Ment Health; 2001 Aug; 5(3):235-41. PubMed ID: 11575062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments.
    Liu CS; Ruthirakuhan M; Chau SA; Herrmann N; Carvalho AF; Lanctôt KL
    Curr Alzheimer Res; 2016; 13(10):1134-44. PubMed ID: 27137221
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 2023 update on the advancements in the treatment of agitation in Alzheimer's disease.
    Lee D; Clark ED; Antonsdottir IM; Porsteinsson AP
    Expert Opin Pharmacother; 2023 Apr; 24(6):691-703. PubMed ID: 36958727
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Agitation and other noncognitive abnormalities in Alzheimer's disease.
    Deutsch LH; Rovner BW
    Psychiatr Clin North Am; 1991 Jun; 14(2):341-51. PubMed ID: 1676506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
    Raskind MA; Wang LY
    Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
    [No Abstract]   [Full Text] [Related]  

  • 50. To prescribe or not to prescribe? Atypical antipsychotic drugs in patients with dementia.
    Jeste DV; Meeks T
    South Med J; 2007 Oct; 100(10):961-3. PubMed ID: 17943030
    [No Abstract]   [Full Text] [Related]  

  • 51. Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.
    Lopez OL; Wisniewski SR; Becker JT; Boller F; DeKosky ST
    Arch Neurol; 1999 Oct; 56(10):1266-72. PubMed ID: 10520944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology.
    Schneider LS; Tariot PN; Lyketsos CG; Dagerman KS; Davis KL; Davis S; Hsiao JK; Jeste DV; Katz IR; Olin JT; Pollock BG; Rabins PV; Rosenheck RA; Small GW; Lebowitz B; Lieberman JA
    Am J Geriatr Psychiatry; 2001; 9(4):346-60. PubMed ID: 11739062
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dementia update. Pharmacologic management of agitation and psychosis in older demented patients.
    Zaraa AS
    Geriatrics; 2003 Oct; 58(10):48-50, 52-3. PubMed ID: 14569642
    [No Abstract]   [Full Text] [Related]  

  • 55. Psychotic symptoms, aggression and restlessness in dementia.
    Ballard C; Gray A; Ayre G
    Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The emergency treatment of depression complicated by psychosis or agitation.
    Glick RL; Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
    Kurlan R; Cummings J; Raman R; Thal L;
    Neurology; 2007 Apr; 68(17):1356-63. PubMed ID: 17452579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A double-blind randomized placebo-controlled withdrawal trial comparing memantine and antipsychotics for the long-term treatment of function and neuropsychiatric symptoms in people with Alzheimer's disease (MAIN-AD).
    Ballard C; Thomas A; Gerry S; Yu LM; Aarsland D; Merritt C; Corbett A; Davison C; Sharma N; Khan Z; Creese B; Loughlin P; Bannister C; Burns A; Win SN; Walker Z;
    J Am Med Dir Assoc; 2015 Apr; 16(4):316-22. PubMed ID: 25523285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacologic interventions for psychosis and agitation in neurodegenerative diseases: evidence about efficacy and safety.
    Weintraub D; Katz IR
    Psychiatr Clin North Am; 2005 Dec; 28(4):941-83, ix-x. PubMed ID: 16325736
    [No Abstract]   [Full Text] [Related]  

  • 60. The role of typical and atypical antipsychotic medications in the management of agitation and aggression.
    Buckley PF
    J Clin Psychiatry; 1999; 60 Suppl 10():52-60. PubMed ID: 10340688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.